Korea readies ‘preferential drug pricing’ for innovative medicines

The Korean government will consider introducing a “preferential drug pricing system” to support innovative pharmaceutical companies. Although the system had a legal basis, the government has not introduced it because it posed a trade dispute risk. However, the Ministry of Health and Welfare said it would find ways to introduce it without trade dispute concerns as part of the national strategy to develop key leading industries.

Read the source article at koreabiomed.com
2021-08-30 07:02:37